Inhibition of tumour necrosis factor alpha in the R6/2 mouse model of Huntington's disease by etanercept treatment.

Sci Rep · 2019 · PMC6510744 · PMID 31076648

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

failed to reach statistical significanceno p-value reported

There was a trend for IL1β levels to progressively decrease for up to 5 days post injection but this failed to reach statistical significance (Fig. 2b ).

also in 6,035 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.